Omega-3 Fatty Acid may Help Keep Heart Disease Risk at Bay: StudyMonday, February 20, 2017
U.S., Jan. 10 -- A recent study highlighted in the journal Mayo Clinic Proceedings has revealed that a minimum of 1 g/day of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), as recommended by the American Heart Association (AHA), may potentially help scale back the odds of coronary heart disease (CHD) events - defined as myocardial infarction (MI), sudden cardiac death, coronary death, or angina. A team of researchers at EpidStat Institute conducted a meta-analysis of randomized controlled trials (RCTs) and found that the consumption of omega-3 fatty acids (EPA/DHA) from food or supplements was tied to a nonsignificant 6 percent lower rate of CHD as compared to controls. In addition, the investigators found that the intake of omega-3 fatty acid was related to a considerably decreased risk of CHD among patients having high initial levels of triglycerides or LDL cholesterol. When the experts reviewed prospective observational cohort studies, they found that high consumption of omega-3 fatty acid was linked to a significant 18 percent lower rate of CHD as compared to low intake.